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Asthma and atopy, classically associated with hyper-activation of the T helper 2 (Th2) arm of adaptive immu-
nity, are among themost common chronic illnesses worldwide. Emerging evidence relates atopy and asthma
to the composition and function of the human microbiome, the collection of microbes that reside in and on
and interact with the human body. The ability to interrogate microbial ecology of the human host is due in
large part to recent technological developments that permit identification of microbes and their products us-
ing culture-independent molecular detection techniques. In this review we explore the roles of respiratory,
gut, and environmental microbiomes in asthma and allergic disease development, manifestation, and atten-
uation. Though still a relatively nascent field of research, evidence to date suggests that the airway and/or gut
microbiome may represent fertile targets for prevention or management of allergic asthma and other dis-
eases in which adaptive immune dysfunction is a prominent feature.The Human Microbiome
The field of microbiology owes its genesis to observations made
by Antonie van Leeuwenhoek, a Dutch microscope lens maker
who, in 1676, first described microscopic ‘‘animalcules’’ in
dental plaque (Porter, 1976). For much of the ensuing history of
the field, research has largely focused on culture-based studies
of individual microbial species, with an emphasis on understand-
ing the basis of microbial pathogenesis. However, over the past
30 years, the sub-specialty of microbial ecology has driven
development of molecular methods for microbial detection that
obviate the necessity for microbial culture. These efforts have re-
vealed the existence of a vast diversity of microbes that inhabit
natural systems and demonstrated that these organisms rarely
exist in isolation, but instead occur in multi-species, multi-func-
tional communities.
Pioneered by Dr. Carl Woese, the use of molecular techniques
to classify microbes without recourse to laboratory culture-
based approaches led to the subsequent development of the
16S rRNA gene as a widely used bacterial biomarker for profiling
bacteria present in a mixed-species community. This gene,
which is exclusive to and ubiquitous among bacteria (Fox
et al., 1977; Winker and Woese, 1991; Woese, 1987), is a useful
molecular target for bacterial identification due to the presence
of regions of sequence that are highly conserved across the
majority of known bacteria. These conserved sequences flank
hyper-variable regions, reflective of varying evolutionary rates
across bacterial species. The conserved 16S rRNA sequence re-
gions permit design of PCRprimers and amplification of the gene
(or a portion thereof) from the majority of known bacterial spe-
cies. The amplified hyper-variable region is typically sequenced
to permit classification of amplicons into discrete taxonomic
groups, generating a fingerprint of bacterial phylotypes within
a given community. Application of ecological statistics and
theory to these profiles allows for analyses and interpretation592 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.of the composition of microbial communities. Distinct biomar-
kers, e.g., the internal transcribed spacer region 2 (ITS2) of the
fungal rRNA gene, are used for mycological community profiling,
which is performed in a similar manner. More recent advances
and declining costs associated with high-throughput seq-
uencing platforms have permitted more expansive microbial
biomarker sequencing efforts, leading to identification of novel
microbial species, expansion of the known microbial tree of
life, and an enhanced appreciation of the diversity of microbes
that inhabit natural systems. This increase in sequence capacity
has also led to the development of complementary microbiome
analyses tools, including shotgun sequencing approaches to
determine the functional genes encoded or expressed by a mi-
crobial community (metagenomics or metatranscriptomics, res-
pectively; Figure 1). Parallel advances in mass spectroscopy
platforms have led to improvements inmethods for detectingmi-
crobial products, including the dominant proteins (metaproteo-
mics) or metabolites (metabolomics) collectively produced by
microbial members within a community (Figure 1). As the field
continues to rapidly evolve, efforts are becoming more focused
on integration of these approaches to produce a more compre-
hensive view of microbial community composition and function.
Though microbial ecology research has traditionally focused
on terrestrial and aquatic ecosystems, more recently, predomi-
nantly biomarker-based microbial profiling techniques have
been applied to the study of the human microbial ecosystem.
The results have led to amore comprehensive view of the healthy
human body as a series of ecosystems, each with its own partic-
ular microbial composition, when considered at the broadest
(phylum) level of classification. It has been estimated that micro-
bial cells outnumber human cells by approximately 10-fold (Sav-
age, 1977) and that healthy humans possess 500–1,000 distinct
bacterial phylotypes (Claesson et al., 2009; Frank et al., 2007).
Though much research has focused on bacterial communities
Figure 1. Molecular Tools for Interrogating
Microbiome Composition and Function
DNA, RNA, protein, and metabolite fractions of the
samples may be interrogated using next-genera-
tion sequencing andmass spectroscopy platforms
to assess microbiome composition and function.
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detected in these assemblages. The genetic capacity of such a
diverse microbial ecosystem is immense; the pan-genome of
the healthy human microbiome is estimated to encode approxi-
mately 100 times the number of genes found in the human
genome. Though the genomic capacity of the healthy gut micro-
biota, where much research has focused to date, is predomi-
nantly encoded by bacteria, fungal and archaeal genes are also
present in this consortium, though their functional contribution
to host health status is as yet largely undefined (Qin et al., 2010).
Microbial members of the human super-organism contribute
critical functions to their host, including enzymic digestion
of complex carbohydrates; gastrointestinal microbes digest
fermentable fiber to produce short-chain fatty acids (SCFAs;
Roediger 1980), an essential energy source for the epithelial
cell lining of the gut (Kaneko et al., 1994; Flint et al., 2008).
Production of SCFAs also acidifies the local gastrointestinal
microenvironment, making it less hospitable for colonization or
overgrowth of pathogenic species such as Escherichia coli and
Salmonella spp. (Cherrington et al., 1991). Commensal microbes
also engage in competitive colonization, which provides further
protection against pathogen overgrowth. The gut microbiome
also biosynthesizes essential vitamins and hormones (Yatsu-
nenko et al., 2012), as well as a range of anti-inflammatory com-
pounds (Herbst et al., 2011; Mazmanian et al., 2008; Round and
Mazmanian, 2010; Sokol et al., 2008). Our reliance on microbial
function is evident from the critical role microbes play in
mammalian development; germ-free mice are both immunolog-
ically and physiologically aberrant, a phenotype that can only be
rescued through introduction of commensal bacteria (Atarashi
et al., 2011; Smith et al., 2007). Beyond early-life development,
evidence has emerged that the microbiome influences the tone
of host immune response, particularly that of the adaptive arm.
Specific Clostridium species belonging to clade IV or XIVA as
well as members of the Bacteroides exhibit the capacity to
induce T regulatory (Treg) cells, which are essential for immune
tolerance and abrogation of chronic inflammatory or autoim-
mune disease (Atarashi et al., 2011; Ochoa-Repa´raz et al.,Cell Host & Microbe2010). In addition, murine studies have
demonstrated the capacity of specific
species in the gut microbiome to induce
discrete arms of the adaptive immune
response. Black 6 mice whose ileum is
overtly colonized by segmented filamen-
tous bacteria (SFB) exhibit robust prolifer-
ation of IL-17- and IL-22-expressing T
helper 17 (Th17) cells (Ivanov et al.,
2009). This phenotype could be conferred
to Th17 deficient mice by co-housing with
SFB colonized mice or by transfer of fecal
material from SFB mono-colonized ani-mals. SFB, an unculturable member of the Clostridiales, was
identified as the species responsible for induction of Th17 cell
proliferation through culture-independent microbiome profiling
(Ivanov et al., 2009). However, perhaps more importantly,
these studies demonstrate a direct role for microbiome mem-
bers in the promotion of distinct adaptive immune responses
associated with protection against or development of a range
of chronic inflammatory and autoimmune diseases. These
pertinent observations in mice raise the possibility that diseases
associated with overactive arms of adaptive immunity may owe
their genesis to microbiome dysbiosis and related dysfunction.
It also raises the possibility that diseases currently associated
with ‘‘inappropriate immune activation’’ may in fact represent
perfectly appropriate host immune responses to specific patho-
genic microbiome compositions and their related activities that
promote immune activation.
The Asthmatic Airway Microbiome
Asthma is estimated to affect approximately 300 million individ-
uals worldwide, incurs significant health care expenditure (Ac-
cordini et al., 2013; Barnett and Nurmagambetov, 2011), and is
one of the most common chronic diseases. Given increases in
disease prevalence over the last several decades, it is predicted
that the number of individuals affected worldwide will increase
by 100 million people by 2025 (Masoli et al., 2004). In the United
States, the risk of developing asthma is highest for children dur-
ing the period between birth and four years of age (Jackson et al.,
2014); disease prevalence is also higher among women, families
below the poverty line, and people of multiple races compared to
other groups (Akinbami et al., 2009). Though risk alleles have
been associated with asthma development (reviewed in Ober
and Yao, 2011), the rapid increase in prevalence over the recent
decades, particularly among children, points to environmental
factors playing a key role in disease development (Cookson
and Moffatt, 1997). Atopic sensitization (allergy), characterized
by elevated levels of total and allergen-specific IgE in the serum
and typically by positive skin-prick tests to at least one of a panel
of common allergens, is considered the strongest risk factor for17, May 13, 2015 ª2015 Elsevier Inc. 593
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et al., 2010), and its rise is associated with a parallel increase in
asthma prevalence (Masoli et al., 2004). More recently, an unsu-
pervised statistical approach to pediatric subject clustering,
based on the range and degree of their atopic sensitization, re-
vealed that subjects that were predominantly multi-sensitized
to common food and aero-allergens had the highest risk of sub-
sequently developing asthma in childhood (Havstad et al., 2014;
Simpson et al., 2010).
Allergic asthma is a heterogeneous and complex disease,
clinically defined as reversible airflow obstruction and immuno-
logically by hyper-activation of the T helper 2 (Th2) arm of the
adaptive immune response and the overexpression of the pro-in-
flammatory cytokines IL-4, IL-5, and IL-13, as well eosinophilia
and mast cell infiltration of the airways (Adcock et al., 2008).
Asthma is difficult to diagnose because of inherent heterogeneity
across asthmatic patient populations and the multiple contribu-
tory factors such as risk alleles, environmental exposures, and
lung function (reviewed in Chung et al., 2014). Patients are
commonly stratified using a range clinical parameters including
bronchial hyper-responsiveness to methacholine (a drug that
promotes bronchoconstriction), as well as medication use and
frequency of exacerbation. Recently, unsupervised statistics
have been used to improve diagnosing asthma and its severity
(Chung et al., 2014).
However, emerging evidence indicates that other distinct im-
mune phenotypes exist among discrete asthmatic patient sub-
populations; recent studies have demonstrated an association
between T helper 1 (Th1) cells specifically in obesity-related
(Rastogi et al., 2012) and smoking-induced asthma (Tsoumaki-
dou et al., 2007). Additionally, among asthmatic populations, a
recent study distinguished two patient subgroups, Th2-high
and Th2-low, which evenly divided the cohort under study
(n = 22 and n = 20, respectively; Woodruff et al., 2009). Th2-
high patients exhibited significantly increased expression of
three biomarker genes (POSTN, CLCA1, and SERPINB2) and
of the Th2 cytokines IL-5 and IL-13, but not IL-4. They exhibited
increasedmucin stores (as indicated by increasedMUC5AC and
MUC2 expression) and more severe airway hyper-responsive-
ness, as measured by the provocative concentration of metha-
choline necessary to reduce the forced exhibitory volume in
one second by 20% from baseline, more commonly known as
the PC20 test. Th2-low individuals consist of both asthmatic
and non-asthmatic subjects and characteristically exhibit low
levels of both Th2 cytokines and the three-gene biomarker
expression. While Th2-high and Th2-low asthmatics do not differ
in disease severity, they react distinctly to inhaled steroids; only
Th2-high asthmatics respond to corticosteroids, a common
treatment for asthma. These findings clearly require validation
in multiple large cohorts; however, they suggest that Th2 hetero-
geneity exists among asthmatics and may represent a critical
approach to stratifying patients. Given the existing evidence
for microbial activation of T cell subsets in the gastrointestinal
tract, the current hypothesis is that the overall heterogeneity in
asthma-associated immune dysfunction is related to the pres-
ence of distinct microbial populations in the airways. While
several groups have long postulated that asthma is an infectious
disease caused by bacterial pathogens (reviewed in Kraft, 2000),
it has only been the relatively recent application of culture-inde-594 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.pendent microbiome profiling approaches to asthmatic airway
samples that has revealed the diversity of microbes that exist
in the asthmatic airway and that relationships do exist between
microbial members within these communities and features of
the disease.
Multiple studies of asthmatic patient cohorts using distinct
microbiome platforms (next-generation sequencing and phylo-
genetic microarrays) have reported the presence of a diversemi-
crobial community in the airways of these patients. These micro-
biota are commonly enriched for members of the Proteobacteria
(Goleva et al., 2013; Hilty et al., 2010; Huang et al., 2011). When
compared to healthy subjects (few of which possessed sufficient
bacterial material for 16S rRNA-based microbiome profiling),
asthmatics possessed significantly higher bacterial burden and
diversity in their lower airways (Huang et al., 2011). The finding
of a characteristically low bacterial burden in the lower airways
of healthy subjects was supported by a separate study of
bronchoscopic lower airway samples, which found that the
lower airway microbiome differed from the upper by having
lower biomass but being compositionally similar, consisting of
members of the Staphylococcaceae, Propinobacteriaceae, Cor-
ynebacteriaceae, Streptococcaceae, Veillonellaceae, and Pre-
votellaceae (Charlson et al., 2011). Marri et al. (2013) reported
a slightly different community for non-asthmatics based on
induced sputum samples that consisted of members of the
Lachnospiraceae, Staphylococcaceae, Streptococcaceae, Car-
nobacteriaceae, Fusobacteriaceae, and Peptostreptococca-
ceae. This compositional differential between the two studies
may be a function of sampling distinct compartments within
the lower airways (i.e., induced sputum versus bronchoalveolar
lavage [BAL]).
The airway microbiome composition of asthmatic patients is
highly correlated with the degree of bronchial hyper-responsive-
ness (a characteristic feature of allergic airways), thus raising the
possibility that specific bacterial members within the asthmatic
airway microbiome may potentiate airway allergic responses.
Additional evidence of a relationship between airway micro-
biome composition and disease characteristics comes from a
study of corticosteroid-responsive (CS) or -resistant (CR) pa-
tients. Goleva and colleagues (2013) demonstrated the presence
of distinct lung microbiomes in CS and CR patients. CR patients
were enriched in Proteobacteria, including Neisseria and Hae-
mophilus, which possess lipopolysaccharide (LPS) with short
acyl chains known to have high endotoxic activity and an
enhanced capacity to trigger Toll-like receptor 4, leading to
pro-inflammatory IL-8 production. Conversely, CS patient mi-
crobiomes were predominantly populated with Bradyrhizobium
and Fusobacterium members, possessing longer acyl chain
LPS purported to confer relatively lower endotoxicity with
reduced capacity to induce innate immune host responses.
How these distinct microbiome features relate to steroid respon-
siveness remains unclear, though it is tempting to hypothesize
that discrete functional features of these compositionally distinct
airway communities, such as steroid degradation capacity, ac-
count for this dichotomy in steroid responsiveness.
Emerging evidence also suggests that the bacterial microbiota
that colonizes the respiratory mucosa may also impact host
response to viral infection. Severe respiratory viral infection
with respiratory syncytial virus (RSV) and rhinovirus (RV) is
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such, these viruses are considered asthmagenic. Mice nasally
exposed to two distinct strains of the commensal bacterial spe-
cies Lactobacillus rhamnosus (LR05 and LR06) were protected
against subsequent RSV infection. Protection was associated
with increased levels of IFN-b, IFN-g, IL-6, and TNF-a in both
BAL and serum samples, which contributed to viral clearance.
In parallel, animals exhibited elevated levels of the anti-inflam-
matory cytokine IL-10, which reduced inflammation-associated
lung tissue damage (Tomosada et al., 2013). In this study the
authors demonstrated that the specific strain of L. rhamonsus
mattered; strain Lr05 was found to be more effective in
increasing IFN-g and IL-10 compared with strain Lr06, but Lr06
was more efficient in increasing IFN-b, TNF-a, and IL-6, thus
emphasizing the capacity of distinct strains of the same species
to elicit discrete host responses.
Other studies have demonstrated that the presence of specific
pathogenic species in the airway potentiates RV infection in chil-
dren (Kloepfer et al., 2014). Risk of asthma exacerbation signifi-
cantly increased when RV was found concurrently with airway
Moraxella catarrhalis,Streptococcus pneumoniae, orHaemophi-
lus influenzae compared with children with neither bacterial nor
viral pathogens. In addition, the odds of experiencing illness
symptoms for more than 2 days were significantly higher when
Moraxella catarrhalis or Streptococcus pneumoniae was de-
tected concurrently with RV when compared to children who
did not possess these bacterial or viral pathogens. Detection
of airway pathogens did not predict RV presence, but discovery
of RV increased the chances of detecting these bacterial patho-
gens; RV infection was associated with increased burden of
each of three pathogenic bacteria examined, suggesting RV
may change the airway environment in a manner that permits
outgrowth of these respiratory pathogens, which in turn poten-
tiate the effect of this respiratory viral infection. A previous
independent study demonstrated that the same three bacterial
species and viruses were associated with wheezy episodes in
children (Bisgaard et al., 2010). However, this study included
eight additional viruses, which may have masked the interactive
effect of RV and bacteria.
Development of the nasopharyngeal microbiome in the first
year of life has been linked to the risk of asthma development
(Teo et al., 2015). In a longitudinal study of postnasal aspirates
of 234 children in Australia, six distinct bacterial microbiota types
were identified. Each was characterized by the presence of a
particular dominant genus: Moraxella, Streptococcus, Coryne-
bacterium,Staphylococcus,Haemophilus, orAlloicoccus. Those
genera that have previously been associated with airway dis-
ease, e.g., Moraxella, Streptococcus, and Haemophilus, were
also linked in this study to increased risk of asthma development.
Airway communities dominated by these three specific genera
during an airway respiratory infection in infants who were later
diagnosed with atopy (at age 2) was associated with increased
risk of lower airway infection and febrile symptoms. Airway mi-
crobiota dominated by Streptococcus were significantly associ-
ated with both lower respiratory infection at a younger age and
chronic wheeze. Also, the age of bacterial colonization appears
important, since the risk of developingwheeze at age 5was high-
est when a high abundance of Streptococcus was found at age
7 weeks compared to 8 or 9 weeks of age. Moreover, the studydemonstrated that the composition of the nasopharyngeal mi-
crobiome of these children is related to early-life exposures
such as day care and antibiotic administration, indicating that
airway mucosal colonization, like the gastrointestinal tract
(see below), is influenced by local exposures during the critical
period of microbiome development in neonatal life and early
infancy. This large study of several hundred children demon-
strates relationships between patterns of early-life bacterial
colonization and respiratory infection, recurrent wheeze and
asthma, strengthening the hypothesis that microbial mucosal
colonization plays a critical role in airway disease susceptibility.
Amore comprehensive review of themicrobiome and respiratory
infection is covered by Vissers and colleagues (2014).
While the lower airways do not appear to be overtly colonized
in healthy humans, the oropharynx supports a thriving and
diverse microbial ecosystem (Huttenhower et al., 2012; Lemon
et al., 2010). Early-life perturbations to this community have
been linked to childhood asthma development. Neonates whose
oropharynx were colonized by a high burden of Streptococcus
pneumonia, Haemophilus influenzae, or Moraxella catarrhalis
within the first month of life had an increased risk for recurrent
wheeze and asthma development, significantly higher counts
of eosinophils, and elevated levels of total serum IgE (Bisgaard
et al., 2007). However, infants colonized by these same species
at 12months of age did not incur the same risk for disease devel-
opment, suggesting that very-early-life microbial colonization
patterns may strongly influence immune development in a
manner that is skewed toward allergic response, and that the ac-
tivities of these species is contextual, and perhaps dependent on
age-dependent changes in the local microbiome in this niche
(Figure 2). Support for this hypothesis comes from early-life
airway studies in mice. Recently, the lower respiratory micro-
biome was also shown in a murine model to play a role in
the allergic immune response development against house
dust mites (HDM; Gollwitzer et al., 2014). Programmed death
ligand 1 (PD-L1) is necessary for the development of T regulatory
cells, which lack expression of the Helio transcription factor
(Helio Tregs). These cells, which reside in the lungs, are
inversely related to aeroallergen response to HDM. Within the
first 2 weeks of life, PD-L1 expression peaked in the murine
lungs; this occurred in parallel with changes in bacterial burden
and composition. However, this temporal gene expression
pattern is absent in germ-free animals, suggesting that the pres-
ence of microbes is necessary for PD-L1 expression and expan-
sion of Helio Tregs. Collectively, these data point to an immune
maturation process in the respiratory mucosa that parallels that
which occurs in the gut, both of which are intimately dependent
on (appropriate) microbial colonization.
Early-Life Gut Microbiome and Childhood Allergic
Asthma
While the airway microbiome has naturally formed the focus
of asthma studies, a growing body of epidemiological andmicro-
biological literature supports the hypothesis that the genesis
of allergic disease, and by extension asthma development,
may lie at least in part in the communities of microbes that
exist in the gastrointestinal tract. Support for this phenomenon
comes from factors that have been identified as related to allergic
disease development in childhood. These include early-lifeCell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc. 595
Figure 2. Very-Early-Life Exposures
Influence Asthma and Allergy Development
Oropharyngeal colonization of neonates by Strep-
tococcus, Haemophilus, or Moraxella species at
4 weeks of age is associated with development of
recurrent wheeze. Infants colonized at 12 months
with the same species were not at higher risk.
Dysbiotic neonatal (3-week-old) gut microbiomes
enriched with Escherichia coli or Clostridium diffi-
cile are at significantly higher risk for childhood
atopy development, which is typically character-
ized by elevated serum IgE levels.
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(Renz-Polster et al., 2005), formula feeding (FriedmanandZeiger,
2005; Harmsen et al., 2000), lack of maternal exposure to pets or
livestock during pregnancy (Ownby et al., 2002), and maternal
consumption of antimicrobials during pregnancy (Stensballe
et al., 2013). Fromamicrobiological standpoint, these risk factors
have the capacity to influence microbiome composition; this
has been clearly demonstrated for antimicrobial administration,
which acutely depletes gut microbiome diversity (Dethlefsen
and Relman, 2011), while formula feeding has been shown to
deplete commensal Bifidobacteria populations in the infant gut
(Balmer and Wharton, 1989; Bullen et al., 1976; Yoshioka et al.,
1983). That the identified risk factors are focused around the
pre- and early post-natal period suggests that development of
childhood allergic asthma may owe its genesis, at least in part,
to microbiome perturbations in early life during the critical period
of microbiological and immunological development. In support
of this hypothesis, independent studies have demonstrated
that 3-week-old neonates who possessed significantly higher
fecal burden of Clostridium difficile and a higher C. difficile to
Bifidobacteria ratio had a significantly higher rate of atopy devel-
opment (Kallioma¨ki et al., 2001). In a separate study, infantswith a
high abundance of fecal Escherichia coli developed IgE-associ-
ated eczema (Penders et al., 2006).
To understand how these early-life risk factors may be related
to disease development, it is first necessary to consider micro-
biome development in early infancy. Recent studies have
described a placental (Aagaard et al., 2014) and cord blood
(DiGiulio et al., 2008)-associated microbiome, raising the pros-
pect of microbial exposure in utero. However, the birthing
process appears to represent a strong microbiological influence
on the neonate. At birth, vaginally delivered infants are colonized
at various sites (skin, mouth, gut) by a microbiome enriched
for Snethia and Lactobacillus spp., which is most similar in
composition to that found in their mother’s vaginal tract (Domi-596 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.nguez-Bello et al., 2010). In comparison,
Caesarian-born infants (who are at signif-
icantly higher risk of allergic disease
development [Renz-Polster et al., 2005])
typically begin life with a microbiome en-
riched with Staphylococcus and Strepto-
coccus spp. and a microbiome most
similar to that of the maternal skin micro-
biome (Dominguez-Bello et al., 2010).
Ecologically, development of the gut
microbiome follows the central tenets of
primary succession, a well-establishedseries of events that occur during the initial colonization of a
previously pristine environment. Pioneer species, i.e., those
that initially colonize and ecosystem, frequently determine
ecosystem conditions and dictate the types of organisms that
co-colonize the niche. This raises the possibility that early
aberrant microbial colonization in the gut, as described by Pen-
ders et al. (2006) and Kallioma¨ki and colleagues (2001) (or
indeed, the airway), may lead to dysbiotic microbiomes lacking
commensal species necessary for appropriate physiological
and immune development and subsequent maintenance of im-
mune homeostasis. Hence, early-life microbiome development
may prove a critical factor in dictating both immune maturation
and childhood allergic disease development.
Support for this hypothesis comes from studies of mice colo-
nized in early life by a cocktail of 46 spore-forming Clostridium
clade IV and XIV species (Atarashi et al., 2011) or, in an indepen-
dent study, by a diversity of bacteria (Cahenzli et al., 2013). In
both studies, early-life bacterial colonization resulted in signifi-
cantly decreased circulating IgE concentrations (elevated serum
IgE is a hallmark of atopy) in adulthood. However, supplementa-
tion of adult animals with these same bacterial cocktails did not
lead to protection. CD4+ Foxp3-expressing Treg cells represent
an important subset of T helper cells with respect to allergic
asthma, because of their capacity to mitigate pro-inflammatory
adaptive immune response via the production of IL-10 (Barnes
and Powrie, 2009; Rubtsov et al., 2008). In addition to demon-
strating reduced IgE responses, Atarashi and colleagues (2011)
demonstrated, using an IL-10 reporter mouse, that supplemen-
tation of mice with Clostridia IV and XIV members promoted
Treg proliferation in the colon and decreased IL-4 concentrations
in the airways in response to ovalbumin (OVA) challenge, indi-
cating that appropriate gastrointestinal microbial colonization
in early life leads to induction of immune tolerance (Figure 3).
In an independent study, Geuking et al. (2011) also showed that
colonization of germ-freemicewith Altered Schaedler Flora (ASF),
Figure 3. Adaptive Immune Modulation in
theGut andAirways throughGastrointestinal
Microbiome Manipulation
(A) Lactobacillus johnsonii supplementation leads to
decreased numbers of activated dendritic cells (DC)
in the mesenteric lymph nodes (MLN) and a parallel
decrease in Th2 cytokine expression (IL-4, IL-5,
IL-13, IL-17) and DCs in the lungs.
(B) Mice supplemented by a cocktail of Clostridium
IV and XIV species exhibit an increase in colonic T
regulatory cells and the anti-inflammatory cytokine
IL-10 and were protected against ovalbumin-
induced allergic diarrhea in part due to decreased
levels of serum OVA-specific IgE and IL-4.
(C) Feeding propionate to mice resulted in circula-
tion of short-chain fatty acids (SCFAs), associated
with increased common and macrophage DC
precursor cells (LinCKitLo Flt3+ CDPs and
LinCKitHi Flt3+ MDPs, respectively), which is
associated with reduced DC proliferation and Th2
reactivation in the lungs.
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cies, ASF356, ASF502; Lactobacillus sp., ASF360; L. murinus,
ASF361; Mucispirillum schaedleri, ASF457; Eubacterium plexi-
caudatum, ASF492; Firmicutes sp., ASF500; and Parabacter-
ioides sp., ASF519; Wannemuehler et al., 2014) induced de
novo Treg proliferation in the colonic lamina propria (LP). Tregs
produced in the periphery (not in the thymus) are known as
induced Tregs (iTreg) and are principally stimulated in the mesen-
teric lymph nodes (MLN), Peyer’s patches, and LP of the small
and large intestines. Mice deficient in iTregs spontaneously
develop Th2-type pathologies characterized by higher percent-
age of CD4+ T cells producing IL-4, IL-13, and IL-5 cytokines in
the MLN, IL-4 in the LP of the large intestine, and IL-13 and IL-5
in the LP of the small intestine (Josefowicz et al., 2012). iTreg-defi-
cient animals possess an altered gut microbiome, enriched with
members of the TM7 phylum, a relatively recently described
candidate division consisting of uncultivated bacteria, as well as
Alistipes species, and also exhibit macrophage and neutrophil
infiltration in the airways coupled with increased goblet cell
numbers, mucin hyper-secretion, smooth muscle hyperplasia,
fibrosis, and poorer lung function (Josefowicz et al., 2012). That
the presence of specific bacterial stimuli have been shown to
be critical to the proliferation of this T helper subsets in mice sug-
gests that failure to populate the developing gastrointestinal mi-
crobiome with such species represents at least one pathway by
which allergic disease may develop.
Invariant natural killer T (iNKT) cells represent another impor-
tant subset of IL-4- and IL-13-producing (Akbari et al., 2003)
lymphocytes that accumulate in the colonic LP and lungs of
germ-free mice. iNKT cells accumulate soon after birth in
germ-free animals, resulting in persistence of the associated
allergic pathology into adulthood. Significantly increased allergic
response in response to airway OVA challenge in germ-freemice
is only abrogated through maternal colonization (and thus
neonatal exposure) when animals are co-housed with specificCell Host & Microbepathogen-free animals (Olszak et al.,
2012). Neonatal protection was due, in
part, to the capacity of commensal organ-
isms to block methylation of chemokine
CXCL16 in the colon and lungs, which iscrucial for iNKT recruitment (Olszak et al., 2012). Colonization
of adult germ-free mice with commensal bacteria did not
abrogate their disease phenotype, indicating that early-life mi-
crobial colonization influences epigenetic modification of host
DNA in a manner that produces life-long effects on the host
immune response. These studies highlight the importance of
appropriate early-life microbiome development in Th2 and al-
lergy-associated phenotypes and suggest that interventions
aimed at correcting dysbiotic microbiomes or promoting appro-
priate colonization in the neonatal phase of life may prove highly
effective in preventing childhood allergic disease.
Environmental Influences on the Developing
Microbiome
Due to the rapid increase in prevalence over the past several
decades, primarily in westernized nations, allergic asthma is
considered a disease that is strongly related to environmental ex-
posures. Emergingevidencesuggests that environmental factors
play an influential role in shaping human-associated microbial
communities and immune responses. A recent study of immune
cell population frequencies, cytokine responses, and serum pro-
teins of 210 healthy twins indicated that 77% of these immuno-
logical parameters were dominated (> 50% of variance) and
58% almost completely determined (> 80% of variance) by
non-heritable influences (Brodin et al., 2015). The study also
demonstrated that immune responses diverged across twin pairs
over time (Brodin et al., 2015), supporting theconcept of aprimar-
ily reactive and adaptive immune response in healthy humans,
presumably in response to local environmental exposures.
Although previous studies have reported that family members
typically possess gut microbiomes that are more similar to each
other than to others (Lee et al., 2011; Turnbaugh et al., 2009; Yat-
sunenko et al., 2012), their similarity was attributed to environ-
mental factors, since the bacterial compositions of monozygotic
twins were no more alike than dizygotic twins (Turnbaugh et al.,17, May 13, 2015 ª2015 Elsevier Inc. 597
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Review2009; Yatsunenko et al., 2012). Diet has been shown to play a
significant role in shaping gut microbiome composition. A recent
murine crossover study highlighted the strong selective pressure
diet exerts on the microbiome. Successively transferring genet-
ically diverse adult mice from high-fat/low fiber to a low-fat/high
fiber diet three times during the course of the study led to similar
shifts in microbiome composition despite the genetic diversity of
the animal population studied (Carmody et al., 2015). The strong
influence of diet on the gut microbiome is also supported by a
study of individuals from Malawi, Venezuela, and the United
States, which demonstrated that the gut microbiome of adult hu-
man subjects in the developing nations was significantly distinct
from that of residents in the United States. While geography and
ethnicity represent potential contributory factors, diet was
considered a primary driver of these compositional and func-
tional differences; developing nation diets were primarily plant
polysaccharide based, while those of U.S. participants was en-
riched in animal products. Functionally, Malawians and Amerin-
dians were enriched for genes encoding glutamate synthase,
associated with herbivores, while gut microbiomes of U.S. par-
ticipants were enriched for the capacity to degrade glutamine,
a function commonly associated with carnivores. Undoubtedly
diet represents a strong selective pressure on the gut micro-
biome, a factor that likely explains the increased risk of allergy
associated with formula feeding. Indeed, studies dating back
to 1936 have reported lower incidences of eczema (Grulee and
Sanford, 1936) and asthma (Friedman and Zeiger, 2005) in
breastfed infants. The lasting effects of breastfeeding have
been reported for children 8 years old, and in an independent
study, infants breastfed for at least 4 months had reduced risk
of developing asthma (Kull et al., 2010).
More recently, early-life microbial exposure in the built envi-
ronment has been linked to allergic asthma development. In
western nations where the burden of allergic asthma is greatest,
exposure to microbes has decreased substantially, most strik-
ingly in the post-industrial revolution era (Rook, 2010). Proposed
in the late 1980s, the hygiene hypothesis encapsulates this
altered human exposure to microbes and posits that a lack of
exposure to commensal microbes represents a driving force in
the increased prevalence of allergic asthma and other chronic in-
flammatory disease in westernized nations (Strachan, 1989). In-
habitants of westernized nations spend almost 90% of their time
in the built environment, with approximately 70%of time spent in
their personal residences (Klepeis et al., 2001). This represents a
significant departure from the environment in which the human
microbiome evolved and has led to the hypothesis that residen-
tial microbial exposures in early life influence microbiome devel-
opment, immune maturation, and consequently the propensity
to develop allergic asthma. In the United States, children raised
in inner-city environments are more likely to develop asthma and
atopy (Crain et al., 1994; Weiss et al., 1992). This observation
was seen to contradict the hygiene hypothesis since the inner
city had always been assumed to represent an environment
of enhanced microbial exposure (Kay, 2001). However, until
recently, no study had comprehensively examined the com-
position of bacterial communities in inner-city households and
whether differences in early-life bacterial exposure related to
allergic asthma development in childhood. Using culture-inde-
pendent profiling, Lynch and colleagues (2014) examined the598 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.bacterial composition of house dust samples collected during
the first year of life from residences in a study of full-term infants
born in low-income, inner-city urban neighborhoods in New
York, Baltimore, St. Louis, and Boston. Children were followed
prospectively, and clinical outcomes of atopy and recurrent
wheeze were assessed at 3 years of age. The investigators
demonstrated that healthy children in the study (who developed
neither atopy nor recurrent wheeze by age 3) were exposed in
the first year of life to richer (increased number of bacterial types)
and more diverse bacterial communities that were of signifi-
cantly distinct composition compared to those in households
where the children developed either atopy or both recurrent
wheeze and atopy. Consistent with the hygiene hypothesis,
healthy inner-city children were exposed to a greater diversity
of bacterial species in early life, characterized by significant
enrichment of approximately 80 bacterial taxa belonging to 16
distinct families. Among those enriched were members of the
Bifidobacteriaceae, which are critical commensal colonizers of
the human gastrointestinal tract, whose loss in early life is asso-
ciated with allergy development (Penders et al., 2007).
Further evidence for the role of local household microbial
exposures in early life in protecting against allergic disease
development comes from an independent study of microbial ex-
posures associated with pet ownership. Exposure to dogs and,
to a lesser extent, cats in infancy protects against allergic dis-
ease development in childhood (Ownby et al., 2002). To deter-
mine whether a microbial correlate of protection existed in these
households, Fujimura et al. (2010) examined both bacterial and
fungal communities in house dust collected during the course
of a prospective birth cohort study centered around the Detroit
metropolitan area. Bacterial communities in household dust
from residences with dogs or cats present were significantly
richer and more diverse compared to those with no pets present
and, as in the inner-city studies, a large majority of bacterial taxa
enriched in the protective environments have previously been
detected in the human gut microbiome (Fujimura et al., 2010).
These findings are consistent with previous lower-resolution
studies in which environments with no pets present are depleted
of bacteria (Gereda et al., 2000; Hesselmar et al., 1999; Ownby
et al., 2002). Moreover, the investigators noted that bacteria-im-
poverished residences that conferred a higher risk of allergic dis-
ease development possessed a wider range of fungal species
(Fujimura et al., 2010). Since fungal species have long been
associated with allergic disease development (Bush and Port-
noy, 2001; Gravesen, 1979; Kurup et al., 2000), this study
suggests that increased local environmental exposure to fungal
species in early lifemay play a role in shaping the neonatal micro-
biome and subsequent allergic disease development.
High-resolution microbiome profiling of the residential envi-
ronment in early life has demonstrated a significant relationship
between early-life bacterial and fungal exposure and allergic
asthma development in childhood. It has been hypothesized
that one mechanism by which these exposures protect against
or contribute to disease development is by influencing the
composition of the gut microbiome, which in turn influences
allergic immune responses. In an attempt to address this hypoth-
esis, Fujimura and colleagues (2014) used a murine model of
airway allergen challenge. In the study, groups of mice were sup-
plemented either with house dust from residences with two dogs
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cockroach allergen. Only animals exposed to dust from homes
with dogs present exhibited significantly reduced airway expres-
sion of Th2 cytokines, IL-4 and IL-13, and the mucin-associated
gob-5 gene. Lung histology supported these findings; protected
animals exhibited pristine airways with no evidence of inflamma-
tory infiltrate or mucin hyper-secretion. Comparative analysis
of the gut microbiome of protected and unprotected animals
revealed significant differences in their taxonomic content.
Protected animals possessed a gut microbiome enriched in
members of the Firmicutes, including taxa belonging to the Lach-
nospiraceae, Bacillaceae, Peptococcaceae, and Lactobacilla-
ceae. Using selective media, the authors isolated and confirmed
that the dominant Lactobacillus in protected animals was Lacto-
bacillus johnsonii, a species that coincidentally becomes highly
enriched in the human vaginal tract immediately prior to birth
(Aagaard et al., 2012) and is thus transferred to the vaginally
born neonate. This suggested that this species may play a
crucial role in shaping gut microbiome composition. Using this
single species, the authors performed subsequent supplemen-
tation experiments using distinct airway allergen challenges
(cockroach and OVA) and demonstrated that animals who
received L. johnsonii were protected against allergen challenge.
Again protection was associated with significant downregulation
of airway Th2 responses (IL-4, IL-5, and IL-13), both at themRNA
and protein level. The study also demonstrated that the protec-
tive effect of L. johnsonii supplementation extended to viral in-
fectious agents, a critical finding since children hospitalized
due to respiratory infection with respiratory syncytial virus
(RSV) have a significantly increased risk of developing allergic
asthma (Darville and Yamauchi, 1998; Stein et al., 1999). Using
this viral pathogen, the investigators demonstrated that oral sup-
plementation with viable L. johnsonii protected against RSV
infection (heat-killed organisms did not confer protection; Fuji-
mura et al., 2014). Protection was again associated with a signif-
icant reduction in both bronchial hyper-activity and the expres-
sion of Th2 and Th17 cytokines (IL-4, IL-5, IL-13, and IL-17)
in the airways. However, these animals did not demonstrate sig-
nificant differences in airway expression of IFN-g compared to
control animals, suggesting that they maintain the capacity to
effectively clear the virus, but significantly downregulated the
adaptive immune responses that are largely responsible for
RSV-associated pathology. Protected animals exhibited a signif-
icantly distinct gut microbial community (from that of susceptible
animals) and significantly reduced activation of dendritic cells
(DCs) in the mesenteric lymph nodes, indicating that composi-
tional (and presumably parallel functional) changes in the gut mi-
crobiome influence the capacity of antigen-presenting cells to
activate local T cell populations, a mechanism by which allergic
responses may be inhibited (Figure 3).
More mechanistic evidence for how the gut microbiome may
prevent allergic response comes from studies demonstrating
the ability of the murine gut microbiota to regulate colonic
T cell populations via production of short-chain fatty acids
(SCFAs) such as butyrate (Furusawa et al., 2013), acetate, and
propionate (Smith et al., 2013). SCFAs are anti-inflammatory
and have been shown to increase significantly with induction
of colonic CD103+ Foxp3+ cells and IL-10 production (Furusawa
et al., 2013; Smith et al., 2013). SCFAs, which are also an impor-tant energy source of gastrointestinal colonocytes, specifically
bind the G protein-coupled receptor 43 (GPR43; also known as
free fatty acid receptor 2 [FFAR2]), which also mediates their ef-
fect on colonic Tregs (Smith et al., 2013). Indeed, Gpr/ mice
exhibit lower IL-10 expression compared to wild-type controls
(Smith et al., 2013) and develop more severe inflammation
when their airways are challenged with OVA (Maslowski et al.,
2009). Microbial-derived SCFAs are produced through the
fermentation of complex carbohydrates. The importance of
these microbial fermentation products in allergic disease was
recently illustrated by Trompette et al. (2014). Mice fed a low-fi-
ber diet followed by nasal exposure to house dust mite (HDM)
extract exhibited significantly increased IL-4, IL-5, IL-13, and
IL-17A in lung tissue as well as increased airway mucus produc-
tion and goblet cell hyperplasia. In parallel, these animals
possessed higher levels of circulating IgE and significantly higher
amounts of total HDM-specific IgG1. In contrast, mice fed a
high-fiber diet prior to HDM exposure were protected, exhibiting
significantly lower cytokine concentrations and a normal mucin
phenotype. Fiber intake impacted the gut microbiome of
animals; a low-fiber diet promoted the abundance of specific
members of Firmicutes, especially those belonging to the Erysi-
pelotrichaceae family, while animals on a high-fiber diet were
enriched for Bacteroidaceae and Bifidobacteriaceae. Supple-
mentation of animals with propionate increased Foxp3+ CD25+
CD4+ Treg cell numbers and enhanced hematopoiesis of DC
precursors. This suggests that SCFAs not only induce iTreg
populations, but also modulate bone marrow-derived antigen-
presenting cell precursors, indicating a mechanism by which
gut microbial-derived metabolites may reprogram the immuno-
logical tone of the human ecosystem. Collectively, these studies
provide evidence that gutmicrobiome composition and activities
influence not only local immune activity, but also that at remote
mucosal sites (Figure 3), suggesting that the microbial commu-
nities resident in the gut may represent a key target for preven-
tion or management of allergic asthma.
While gastrointestinal microbiome manipulation of mice
clearly influences airway immune responses, direct microbial
stimulation of the respiratory mucosa has also been shown to
be protective against Th2-associated allergic responses. Nem-
brini and colleagues (2011) demonstrated that inhalation of
non-pathogenic Escherichia coli was protective against allergic
inflammation (Nembrini et al., 2011). Compared to untreated
animals, mice treated nasally with E. coli prior to OVA allergen
challenge exhibited fewer eosinophils in their lower airways, a
parallel abrogation of IL-4 and IL-5 production, fewer goblet
cells, and pristine lungs as evidenced by histology. These ani-
mals also exhibited airway induction of gdT cells, which pro-
tected mice from airway hyper-responsiveness, but did not
appear to impact cell recruitment. In parallel, innate immune
responses were also impacted. Protected animals exhibited in-
duction of Toll-like receptor 4 (TLR4), which resulted in a sup-
pressive lung environment, altered DC function, and reduced
Th2 effector function in the airways. Other intranasal instillation
studies using a bacterium isolated from cowsheds, Acineto-
bacter lwoffii, also conferred protection against Th2 allergic
airway responses. In this case, protection was associated induc-
tion of the Th1 cytokine IL-12 and a concomitant attenuation
of Th2 responses following allergen challenge (Debarry et al.,Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc. 599
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Review2007). In a separate study, Conrad and colleagues (2009)
demonstrated that the capacity of A. lwoffii to protect against
allergic response could be passed from mother to offspring.
Pregnant mice who received A. lwoffii intranasally during gesta-
tion exhibited significantly increased circulating IL-6 in response
to this microbial exposure (Conrad et al., 2009). Placental con-
centrations of this cytokine were reciprocally related to the con-
centrations found in the maternal circulation and offspring were
less susceptible to airway allergen challenge compared to those
whose mother was not supplemented with A. lwoffi. In this case,
protection appeared to be mediated via innate immune re-
sponses, since the offspring of TLR2/3/4/7/9/ mice supple-
mented with this species were susceptible to airway OVA chal-
lenge. This latter study opens up the possibility that maternal
microbial exposures during pregnancy may influence the sus-
ceptibility to allergic disease development, an area that clearly
merits further intensive study.
In summary, asthma and atopy are complex diseases, which
affect and are affected by the communities of microbes that
colonize the gut and respiratory tracts; these communities in
turn are influenced by an array of environmental influences
from diet and antimicrobial administration to early-life local mi-
crobial exposures. Though many of the studies to date have
been performed in mice, they serve as proof of the existence
of a gut-airway axis. This opens up the possibility that strategies
aimed at manipulating the airway and/or gut microbiome, partic-
ularly in the earliest stages of life when the immune response is
maturing and the microbiome appears most plastic and recep-
tive to exogenous microbes, may serve as a novel strategy for
prevention of allergic asthma, as well as a host of other diseases
in which adaptive immune dysfunction is a prominent feature.
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